As of Jun 21
| +0.02 / +0.07%|
The 3 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +6.76% increase from the last price of 28.10.
The current consensus among 4 polled investment analysts is to Hold stock in NxStage Medical Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.